Lipid Sciences Granted Two Fundamental Viral Immunotherapy Patents Medical News Today (press release), UK - Lipid Sciences, Inc. (NASDAQ: LIPD) announced the issuance of two key patents covering fundamental aspects of the Company's Viral Immunotherapy platform. ... |
Friday, August 8, 2008
Lipid Sciences Granted Two Fundamental Viral Immunotherapy Patents - Medical News Today (press release)
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment